🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety, efficacy and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00703118
Treatments Being Tested
This study will assess the efficacy of boceprevir (BOC) in combination with...
Status
Completed
Location
Multiple Locations
Start Date
2011-10-21
Trial ID
NCT01390844
A Phase 3 study to evaluate the efficacy and safety of two dosing regimens ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00627926
Treatments Being Tested
To demonstrate the effectiveness of DCV 3DAA fixed dose combination with or...
Status
Completed
Location
Scripps Clinic
Start Date
2013-12
Trial ID
NCT01973049
Treatments Being Tested
The aim of the study is to confirm efficacy of treatment for 16 and 24 week...
Status
Completed
Location
1241.20.00026 Boehringer Ingelheim Investigational Site
Start Date
2012-12
Trial ID
NCT01732796
RATIONALE: Romiplostim may cause the body to make platelets. PURPOSE: This...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center
Start Date
2010-06-30
Trial ID
NCT01153919
Treatments Being Tested
The aim of the study is to confirm efficacy and safety of treatment with 60...
Status
Completed
Location
1241.36.00016 Boehringer Ingelheim Investigational Site
Start Date
2012-11
Trial ID
NCT01728324
Treatments Being Tested
This 2 part study will evaluate the efficacy and safety of 12 and 24 weeks ...
Status
Completed
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT00963885
This study involves treatment with boceprevir or placebo in combination wit...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00708500
At least 1 dose of BMS-791325 can be identified which is safe, well tolerat...
Status
Completed
Location
Advanced Clinical Research Institute
Start Date
2010-10
Trial ID
NCT01193361
Treatments Being Tested